Skip to main content
Premium Trial:

Request an Annual Quote

Southern Capitol Ventures Closes $15M Fund, Plans to Invest in Life Science Tool Shops

NEW YORK (GenomeWeb News) – Southern Capitol Ventures, a venture capital firm that focuses on early-stage technology and life science companies in the Southeast and Mid-Atlantic, said today that it has closed on its second fund, worth $15 million.
 
Investors in the fund include Square 1 Bank, Capitol Broadcasting, and individual investors.
 
The firm, based in Raleigh, NC, launched in 2001 with a first fund of just under $5 million. It said its investments for the new fund will be in the range of $100,000 to $1,000,000.
 
Ben Brooks, a founder of Southern Capitol, told Local Tech Wire, a news service based in the Research Triangle Park area, that the company will invest in e-commerce firms as well as bioinformatics startups and “tools and devices on the biotech side.”
 
“We do not invest in molecules. We invest in technology we understand,” Brooks told Local Tech Wire.
 
Southern Capitol’s portfolio companies include Art.com, ChannelAdvisor, Motricity, Eminor, and Synthematix, a cheminformatics firm that was acquired by Symyx Technologies in 2005 for around $13 million.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.